T LYMPHOBLASTIC LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell therapy aims to prevent relapse in aggressive childhood blood cancers
Disease control Not yet recruitingThis early-phase study is testing whether a personalized cell therapy called CD7 CAR-T can help prevent cancer from returning in children and teenagers with high-risk T-cell leukemia or lymphoma. Participants must have already achieved remission with initial chemotherapy. Doctors…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
Major trial aims to boost cure rates for aggressive childhood cancers
Disease control Not yet recruitingThis study is for children and young adults newly diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL). It will test if adding a targeted drug called daratumumab to standard chemotherapy helps patients stay cancer-free longer and impr…
Matched conditions: T LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC